BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 31005928)

  • 1. Plasma NT-proBNP levels associated with cardiac structural abnormalities in asymptomatic health examinees with preserved ejection fraction: a retrospective cross-sectional study.
    Nah EH; Kim SY; Cho S; Kim S; Cho HI
    BMJ Open; 2019 Apr; 9(4):e026030. PubMed ID: 31005928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Diastolic Dysfunction with N-terminal Pro-B-type Natriuretic Peptide Level in Heart Failure Patients with Preserved Ejection Fraction.
    Islam MN; Chowdhury MS; Paul GK; Debnath RC; Shakil SS
    Mymensingh Med J; 2019 Apr; 28(2):333-346. PubMed ID: 31086148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of N-Terminal Pro-B-Type Natriuretic Peptide and Left Ventricular Diastolic Function to Exercise Tolerance in Patients With Significant Valvular Heart Disease and Normal Left Ventricular Systolic Function.
    Hwang JW; Park SJ; Cho EJ; Kim EK; Lee GY; Chang SA; Choi JO; Lee SC; Park SW
    Am J Cardiol; 2017 Jun; 119(11):1846-1853. PubMed ID: 28391990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twist/untwist parameters are promising evaluators of myocardial mechanic changes in heart failure patients with preserved ejection fraction.
    Zhang Y; Li SY; Xie JJ; Wu Y
    Clin Cardiol; 2020 Jun; 43(6):587-593. PubMed ID: 32212277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma N-terminal protype-B natriuretic peptide and restrictive mitral flow to risk-stratify patients with stage B heart failure.
    Dini FL; Whalley G; Poppe K; Fontanive P; Rosa GM; Doughty RN; Di Bello V
    Clin Cardiol; 2009 Dec; 32(12):711-7. PubMed ID: 20027664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The diagnostic value of N-terminal B-type natriuretic peptide in diastolic heart failure: comparison with echocardiographic findings].
    Tuğcu A; Yildirimtürk O; Aytekin S
    Turk Kardiyol Dern Ars; 2009 Mar; 37(2):112-21. PubMed ID: 19404033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of left atrial remodelling and natriuretic peptide levels for preclinical heart failure.
    Tsai JP; Sung KT; Su CH; Lai YH; Kuo JY; Yun CH; Yen CH; Hou CJ; Wu TH; Peng MC; Hung TC; Yeh HI; Hung CL
    ESC Heart Fail; 2019 Aug; 6(4):723-732. PubMed ID: 30993903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of serum N-terminal B-type natriuretic peptide in asymptomatic structural heart disease in Taiwanese population: Comparisons with current ESC Guidelines.
    Hung TC; Wang KT; Yun CH; Kuo JY; Hou CJ; Liu CY; Wu TH; Bezerra HG; Cheng HY; Hung CL; Yeh HI
    Int J Cardiol; 2017 Mar; 231():195-200. PubMed ID: 28087179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]).
    Mishra RK; Li Y; Ricardo AC; Yang W; Keane M; Cuevas M; Christenson R; deFilippi C; Chen J; He J; Kallem RR; Raj DS; Schelling JR; Wright J; Go AS; Shlipak MG;
    Am J Cardiol; 2013 Feb; 111(3):432-8. PubMed ID: 23178053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction.
    Buckley LF; Canada JM; Del Buono MG; Carbone S; Trankle CR; Billingsley H; Kadariya D; Arena R; Van Tassell BW; Abbate A
    ESC Heart Fail; 2018 Apr; 5(2):372-378. PubMed ID: 29345112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amount of left ventricular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction.
    Kim SW; Park SW; Lim SH; Kwon SU; Choi YJ; Park MK; Lee SC; Lee SH; Park JE; Jeon ES
    Clin Cardiol; 2006 Apr; 29(4):155-60. PubMed ID: 16649724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.
    Nolte K; Herrmann-Lingen C; Platschek L; Holzendorf V; Pilz S; Tomaschitz A; Düngen HD; Angermann CE; Hasenfuß G; Pieske B; Wachter R; Edelmann F
    ESC Heart Fail; 2019 Apr; 6(2):262-270. PubMed ID: 30784226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The level of NT-proBNP in ambulatory patients with chronic heart failure with preserved ejection fraction of the left ventricle.
    Kirillova VV; Sokolova LA; Meshchaninov VN; Pershanova VI
    Ter Arkh; 2018 Sep; 90(9):68-72. PubMed ID: 30701738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous estimation of NT-proBNP on top to mitral flow Doppler echocardiography as an accurate strategy to diagnose diastolic dysfunction in HFNEF.
    Kasner M; Gaub R; Westermann D; Kaplan H; Akpulat S; Steendijk P; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2011 May; 149(1):23-9. PubMed ID: 20053469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients.
    Ceyhan C; Unal S; Yenisey C; Tekten T; Ceyhan FB
    Int J Cardiovasc Imaging; 2008 Mar; 24(3):253-9. PubMed ID: 17687631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximum longitudinal relaxation velocity of the left ventricle: its clinical value and relationship with NT-proBNP plasma levels in heart failure.
    Taléns-Visconti R; Rivera M; Climent V; Valero R; Martínez-Dolz L; Sancho-Tello MJ; Cortés R; Miro V; Sevilla B; Perez-Bosca JL; Bertomeu V; Salvador A; Jordan A; Marin F; Sogorb F
    Echocardiography; 2006 Apr; 23(4):295-302. PubMed ID: 16640706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal NT-proBNP: Associations With Echocardiographic Changes and Outcomes in Heart Failure.
    Teramoto K; Tay WT; Tromp J; Ouwerkerk W; Teng TK; Chandramouli C; Liew OW; Chong J; Poppe KK; Lund M; Devlin G; Troughton RW; Doughty RN; Richards AM; Lam CSP
    J Am Heart Assoc; 2024 May; 13(9):e032254. PubMed ID: 38639333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.